Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,580.06
(
0.22%
)
US TECH 100
29,506.00
(
0.28%
)
Dow Jones
51,032.46
(
0.72%
)
Brent Oil
91.36
(
0.00%
)
Bitcoin
73,573.36
(
-0.24%
)
News Focus
News Focus

Replies to post #6724 on Revive Therapeutics Ltd (RVVTF)

Replies to #6724 on Revive Therapeutics Ltd (RVVTF)
icon url

ElJefe80

08/05/20 9:14 AM

#6730 RE: weathervane #6724

You should really read about what "therapy" is....
icon url

OilPatch

08/05/20 9:14 AM

#6731 RE: weathervane #6724

Its a treatment/therapy... gives DOCS an add on to the suite of options. Sounds good to me.

Moving on.
icon url

trademax42

08/05/20 9:19 AM

#6742 RE: weathervane #6724

FDA approved bucillamine for Covid-19 phase 3 studies.

Should I trust your opinion or the FDA's approval?

Oh well I know who to trust!

$RVVTF

all imho only.
icon url

The Whale

08/05/20 9:23 AM

#6749 RE: weathervane #6724

Bucillamine does what a ventilator cannot.
icon url

Natural Trader

08/05/20 9:26 AM

#6753 RE: weathervane #6724

The FDA recommended that the Company proceed directly into a Phase 3 confirmatory clinical trial (“Phase 3 study”) to evaluate Bucillamine for the treatment of patients with mild-moderate COVID-19 due to the SARS-CoV-2 infection in order to ensure expeditious evaluation of the safety and efficacy of Bucillamine.
https://www.globenewswire.com/news-release/2020/04/23/2020948/0/en/Revive-Therapeutics-Announces-U-S-FDA-Recommendation-to-Proceed-Directly-Into-A-Phase-3-Confirmatory-Clinical-Trial.html